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‘Histories of medical lobbying’ 
 
The lobbying of government ministers by medical professionals is a live issue. In 
Britain and around the world medical practitioners have become active in the 
pursuit of legislative change. In the UK, the AllTrials campaign co-founded by the 
physician-researcher Ben Goldacre continues to exert pressure on parliamentarians 
in a bid to force greater transparency in the publication of clinical trial results.  
Meanwhile, the California Medical Association advocates the legalisation of the 
recreational use of marijuana, and doctors in Australia refuse to release child 
refugees from hospital into detention centres damaging to their mental health. It was 
precisely the lobbying of medical humanitarians such as Médecins sans Frontières in 
France that effected a change in the law there in 1998, permitting undocumented 
immigrants with life-threatening conditions to remain in the country for medical 
treatment. 
 
Each of these examples represents an organised attempt on the part of medical 
professionals to change government policy on matters related to public health – in 
other words, lobbying. Yet a recent announcement by the UK cabinet office suggests 
that henceforth recipients of public funding will be banned from directly lobbying 
government ministers in the hope of changing public policy. When questioned in 
parliament David Cameron stated that charities should be devoting themselves to 
‘good causes’ rather than ‘lobbying ministers’. Unless some qualification is 
forthcoming, medical researchers too will be proscribed from carrying out such 
activity. This insinuates that lobbying is in some way outside the proper remit of 
researchers, medical or otherwise.  
 
Yet even a cursory glance at the history of the medical profession’s engagement with 
public health reveals a longstanding and significant engagement with the political 
process.  Medical professionals have been using their scientific expertise as leverage 
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in this way for at least two hundred years. Indeed, the further professionalization of 
medicine in the 19th century, which brought the regulation of practice, changes to 
medical education, and the rise of hospital medicine and laboratory research 
coincided with an increase in parliamentary activity in much of the European and 
North American world. It also ran parallel to the expansion of industrial cities, 
whose physically deprived populations prompted widespread acknowledgement of 
a ‘social question’ in which medical professionals often wished to intervene. By the 
late 19th century one can even speak, as does the historian Jack Ellis, of a ‘hygienic 
crusade throughout Europe’, powered by the efforts of physicians ‘to shift the 
bacteriological revolution from a scientific to a political plane’. If the battle against 
contagious diseases and poor sanitation became a sanctioned sphere of 
parliamentary action in this period, the process of it becoming so owes much to the 
initiative of doctors.  
 
Lobbying strategies have been varied, and variable in their success. The term itself 
developed in the United States in the middle decades of the 19th century, when it 
referred to the process of frequenting the lobby of a legislative assembly for the 
purpose of influencing members’ votes. The practice, however, pre-dated the word. 
It was embraced enthusiastically in the early 19th century by Dr Charles Maclean, one 
of the era’s most strident medical campaigners. Maclean had become convinced that 
the plague was not contagious, and accordingly that quarantine measures imposed 
on ships were unnecessary and positively harmful to health and trade. His attempts 
to persuade colleagues, the public, the East India Company and influential 
politicians such as Sir John Jackson resulted in two parliamentary select committee 
inquiries in 1819 and 1824. As a result, there was some softening of the quarantine 
laws (although not the complete abolition Maclean had desired). Like other radicals 
at this time, Maclean’s approach was strident and provocative. He engaged in 
deliberate attention-seeking behaviour in his attempts to change the views of 
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individual politicians and Parliament, believing that this was the best way for his 
unorthodox views to gain traction.   
 
Some of the most prominent and successful public health campaigns of the 19th 
century hinged on the ability of medical advocates to secure the support of 
influential politicians. The social reformer Edwin Chadwick relied heavily on the 
medical support of Thomas Southwood Smith to secure the Public Health Act in 
1848. Following that enactment, a medical lobbyist working within public 
administration, John Simon (then Medical Officer of Health to the Sewers 
Commission of the City of London), used his annual reports and close connections at 
The Times to convince the public of the importance of his proposed environmentalist 
measures to promote urban sanitation and hygiene.  By the mid-1850s Simon's 
perseverance had won over many who had opposed his views, and in 1859 he 
became the Medical Officer to the Privy Council, providing him with direct 
ministerial access to further his work. 
Innovative medical procedures similarly required political support: Edward Jenner’s 
success in persuading the public to vaccinate owed no small debt to his political 
patrons who helped to secure him a reward in Parliament, thus making the 
‘universal approbation of the House of Commons’ for vaccination widely known. 
Parliament gave further practical support to Jenner’s mission by funding the 
National Vaccine Establishment in 1809. Similarly, the lobbying efforts of the 
Epidemiological Society (a medical pressure group) were crucial in countering 
opponents of vaccination and securing the Vaccination Act in 1853 requiring all 
infants to be vaccinated within three months of birth.  
 
Over time, the medical profession created its own elite bodies designed, in part, to 
channel the collective power of medical expertise on such questions. If the British 
Medical Association (formed in 1832) initially eschewed politics, and has always 
3 
 
sought party political neutrality, its creation in the 20th century of a parliamentary 
medical committee and its use of parliamentary agents, points to the willingness of 
the organisation to engage as directly as possible in the law-making process.  
 
Medical lobbying was equally important in the development of other European 
health systems. In France, a remarkable number of physicians were legislators 
themselves, effecting change from within the system. In the early Third Republic 
(1870-1914) doctors were the second most commonly represented professional group 
in parliament after lawyers: 358 of them were elected as deputies or senators in these 
years. In 1873, Dr Théophile Roussel led the reform of wet nursing, a practice 
unusually prolific in France due to the upsurge of fulltime working women there 
after mid-century, and one that was linked to high infant mortality. Prompted by the 
pressure brought to bear by fellow members of the Academy of Medicine, Roussel 
successfully introduced a parliamentary Bill in 1873 to regulate wet-nursing 
practices through a state system of compulsory registration, surveillance and 
medical inspection. Whether as legislators themselves or members of parliamentary 
committees, French medics successfully argued for the regulation of a host of public 
health menaces in this period – factory conditions, lead paint, contaminated drinking 
water; and they were at the forefront of the fight against typhoid, small pox, cholera 
and tuberculosis.  
 
But it was infant health and the stagnant birth rate that were to prove especially 
emotive, since military defeat in 1870 and the widely publicised decline in live births 
in the 1890s seemed proof to many observers of moral and national decline. The 
extra-parliamentary pressure group founded in 1896 by Dr Jacques Bertillon, the 
national alliance for raising the birth rate, hoped to channel this diffuse sense of 
crisis to legislative ends by softening up both medical and political opinion on the 
issue. Bertillon’s lobbying campaign for taxes on childless couples led to nothing, but 
his proposals were debated in parliament and the 1902 extra-parliamentary 
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commission on depopulation, over half of whose membership comprised 
sympathetic physicians, was set up on his instigation. By 1920 natalists formed the 
largest parliamentary interest group, helping to explain how the Bill introduced in 
that year to curtail the practice of contraception and abortion could pass with 
minimal discussion. 
 
But it is important to remember that none of these medical campaigns was wholly 
uncontroversial. Many (even those that now seem simple common sense to us) faced 
significant political opposition or flew in the face of longstanding and accepted 
conventional wisdom about health and disease. The medical practitioners who 
sought improvements in public health needed to recruit influential supporters, 
willing to listen to and weigh up the research available. Importantly, by taking their 
issues to Parliament these public health initiatives were scrutinized from both a 
scientific perspective, and in the light of prevailing attitudes about what regulation 
of the individual the State could and should support.  Furthermore, the voices of 
doctors were not the only ones struggling to be heard, and they were certainly not 
always determinative. What influence they had depended on a range of structural 
and ideological factors, and on how far doctors were trusted culturally, a nebulous 
status that drew as much on their claims to understand human suffering as their 
scientific credentials.  
 
The history of medical lobbying shows that many of the public health laws that 
sought to combat the spread of infectious diseases, improve sanitation or offer 
medical assistance to the poor, originated in quite deliberate campaigns on the part 
of doctors, acting individually or in professional groups, to effect legislative change. 
This process also forced medical campaigners to present their research in ways 
accessible to the non-expert legislator, and to subject it to broad scrutiny in order to 
be persuasive in a policy context. It appears that this kind of activity became routine, 
and that it was accepted by political elites and the wider public alike.  
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 Advocacy by the health community is especially important because the nature of 
disease is changing. The global health challenges of the 21st century are distinct from 
those of the past – principally unhealthy behaviours related to smoking, alcohol and 
obesity. Such ill health is linked to unhealthy environments in part created by 
commercial operators who spend large sums marketing their brands, leading to 
industrial epidemics of non-communicable disease. According to their annual 
reports, the spirits producer Diageo spent £1,629 million on marketing from sales of 
£10,813 million in 2015, and the ‘market place spend’ of Pepsico amounted to $34.7 
billion from global sales of $66 billion in 2013. Pressure has been brought to bear on 
governments, too. Lobbying by the UK drinks industry recently resulted in a 
complete turnaround on alcohol policy with the revoking of the 2% above inflation 
duty escalator and the defeat of minimum unit pricing, despite the enormous cost to 
the exchequer, running into billions of pounds.  
 
All of this makes the opposition that the UK cabinet office has drawn between 
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